Baseline Characteristics | N (%) |
---|---|
Male | 74 (54) |
Female | 64 (46) |
Age, years | Â |
 <40 | 15 (11) |
 40–50 | 23 (17) |
 51–60 | 45 (33) |
 >60 | 55 (40) |
Baseline BCVA, logMAR | Â |
 0–0.1 | 5 (3) |
 >0.1–0.3 | 29 (20) |
 >0.3–1 | 82 (57) |
 >1 | 28 (19) |
Type of RVO | Â |
 Major BRVO | 60 (42) |
 Macular BRVO | 16 (11) |
 CRVO | 59 (41) |
 HRVO | 9 (6) |
SS-OCT features | Â |
CMT, μ |  |
 < 200 | 13 (9) |
 200–300 | 57 (39.5) |
 > 300 | 74 (51) |
DRIL | 118 (82) |
DROL | 96 (67) |
FFA | 74 (51) |
 Non-ischemic RVO | 28 (38) |
 Ischemic RVO | 46 (62) |
SS-OCTA features | Â |
SCP layer ischemia | Â |
 No detectable ischemic changes | 45 (31) |
 ≥1 quadrant | 99 (69) |
 Perifoveal capillary ischemia | 103 (71.5) |
 Normal vessel density | 33 (23) |
 Reduced vessel density | 111 (77) |
DCP layer ischemia | Â |
 No detectable ischemic changes | 2 (1.3) |
 ≥1 quadrant | 142 (99) |
 Perifoveal capillary ischemia | 137 (95) |
 Normal vessel density | 2 (1.3) |
 Reduced vessel density | 142 (99) |